InsiderFlow

Oncolytics Biotech Inc.

$0.97+0.01 (+1.27%)

Prev Close

$0.96

Open

$0.97

High

$0.99

Low

$0.95

Volume

543.9K

Market Cap

$106.9M

P/E

Div Yield

Over the past 12 months, insider activity at Oncolytics Biotech Inc. (ONCY) has been exclusively buying, with 10 insider purchases totaling $347.5K and 0 insider sales totaling $0.00. The most recent insider transaction was by Andrews Patricia S (Director), who purchased $30.3K worth of shares on Feb 12, 2026. Oncolytics Biotech Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $106.9M.

Buys (12M)

10

$347.5K

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$347.5K

Active Insiders

9

last 12 mo

ONCY Price Chart

ONCY Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Feb 12, 2026Andrews Patricia SDirectorBuy35,400$0.86$30.3K0
Feb 12, 2026Brown Deborah MargaretDirectorBuy25,000$0.85$21.2K0
Feb 12, 2026Hagerman AllisonVP, Product DevelopmentBuy10,000$0.83$8.3K0
Feb 12, 2026Heineman Thomas CharlesChief Medical OfficerBuy12,132$0.83$10.0K0
Feb 12, 2026Look KirkChief Financial OfficerBuy12,000$0.84$10.1K0
Feb 12, 2026Pisano WayneDirectorBuy30,000$0.84$25.3K0
Feb 11, 2026Aromando AndrewChief Business OfficerBuy29,600$0.86$25.4K0
Feb 11, 2026Kelly JaredChief Executive OfficerBuy35,100$0.84$29.5K0
Feb 11, 2026Seizinger Bernd R.DirectorBuy100,000$0.83$83.5K0
Jan 16, 2026Seizinger Bernd R.DirectorBuy100,000$1.04$103.8K0

ONCY Insider Buying Activity

The following table shows recent insider purchases of Oncolytics Biotech Inc. (ONCY) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Feb 12, 2026Andrews Patricia SDirectorBuy35,400$0.86$30.3K0
Feb 12, 2026Brown Deborah MargaretDirectorBuy25,000$0.85$21.2K0
Feb 12, 2026Hagerman AllisonVP, Product DevelopmentBuy10,000$0.83$8.3K0
Feb 12, 2026Heineman Thomas CharlesChief Medical OfficerBuy12,132$0.83$10.0K0
Feb 12, 2026Look KirkChief Financial OfficerBuy12,000$0.84$10.1K0
Feb 12, 2026Pisano WayneDirectorBuy30,000$0.84$25.3K0
Feb 11, 2026Aromando AndrewChief Business OfficerBuy29,600$0.86$25.4K0
Feb 11, 2026Kelly JaredChief Executive OfficerBuy35,100$0.84$29.5K0
Feb 11, 2026Seizinger Bernd R.DirectorBuy100,000$0.83$83.5K0
Jan 16, 2026Seizinger Bernd R.DirectorBuy100,000$1.04$103.8K0

ONCY Insider Selling Activity

The following table shows recent insider sales of Oncolytics Biotech Inc. (ONCY) stock reported via SEC Form 4 filings.

No insider selling activity found for ONCY in the last 12 months.

ONCY Insiders

Andrews Patricia S

Director

Bought $30.3K
1 tradesLast: Feb 12, 2026
Brown Deborah Margaret

Director

Bought $21.2K
1 tradesLast: Feb 12, 2026
Hagerman Allison

VP, Product Development

Bought $8.3K
1 tradesLast: Feb 12, 2026
Heineman Thomas Charles

Chief Medical Officer

Bought $10.0K
1 tradesLast: Feb 12, 2026
Kelly Jared

Chief Executive Officer

Bought $29.5K
2 tradesLast: Feb 12, 2026
Look Kirk

Chief Financial Officer

Bought $10.1K
1 tradesLast: Feb 12, 2026
Pisano Wayne

Director

Bought $25.3K
1 tradesLast: Feb 12, 2026
Seizinger Bernd R.

Director

Bought $187.2K
3 tradesLast: Feb 12, 2026
Aromando Andrew

Chief Business Officer

Bought $25.4K
1 tradesLast: Feb 11, 2026